Matrix metalloproteinases biomarkers in multiple sclerosis

Lancet

Volumn 365, Issue 9467, 2005, Pages 1291-1293

  Rosenberg, Gary A ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BIOLOGICAL MARKER; CYTOKINE; GELATINASE B; MATRIX METALLOPROTEINASE; METHYLPREDNISOLONE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ASTROCYTE; BLOOD BRAIN BARRIER; CELL INFILTRATION; CEREBROSPINAL FLUID ANALYSIS; CONCENTRATION (PARAMETERS); HUMAN; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECURRENT DISEASE; REMISSION; T LYMPHOCYTE;

EID: 17044372776     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)61008-2     Document Type: Note

References (12)

1. VW Yong, S Chabot, O Stuve, G Williams Interferon beta in the treatment of multiple sclerosis: mechanisms of action Neurology 51 1998 682 689
2. R Karabudak, A Kurne, D Guc, M Sengelen, H Canpinar, E Kansu Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients: one year follow-up results J Neurol 251 2004 279 283
3. D Leppert, E Waubant, R Galardy, NW Bunnett, SL Hauser T cell gelatinases mediate basement membrane transmigration in vitro J Immunol 154 1995 4379 4389
4. GA Rosenberg Matrix metalloproteinases and neuroinflammation in multiple sclerosis Neuroscientist 8 2002 586 595
5. K Gijbels, S Masure, H Carton, G Opdenakker Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders J Neuroimmunol 41 1992 29 34
6. GA Rosenberg, JE Dencoff, N Correa Jr, M Reiners, CC Ford Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury Neurology 46 1996 1626 1632
7. MA Lee, J Palace, G Stabler, J Ford, A Gearing, K Miller Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis:a longitudinal clinical and MRI study Brain 122 1999 191 197
8. E Waubant, DE Goodkin, L Gee Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis Neurology 53 1999 1397 1401
9. E Waubant, D Goodkin, A Bostrom IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS Neurology 60 2003 52 57
10. M Yushchenko, M Mader, E Elitok Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis J Neurol 250 2003 1224 1228
11. B Dubois, SM Leary, I Nelissen, G Opdenakker, G Giovannoni, AJ Thompson Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a J Neurol 250 2003 1037 1043
12. GM Liuzzi, M Trojano, M Fanelli Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis Mult Scler 8 2002 222 228